federal_register: 2016-29770
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-29770 | Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs | Notice | The Federal Trade Commission has issued an Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs. The Statement describes the level of substantiation that the Commission expects for marketing claims for over-the-counter (OTC) homeopathic drugs. It also recognizes that marketing claims for OTC homeopathic products for an unsubstantiated indication might be made non-deceptive by the inclusion of additional explanatory information that effectively communicates to consumers that there is no scientific evidence that the product works and that the product's claims are based only on theories of homeopathy from the 1700s that are not accepted by most modern medical experts. | 2016-12-13 | 2016 | 12 | https://www.federalregister.gov/documents/2016/12/13/2016-29770/enforcement-policy-statement-on-marketing-claims-for-otc-homeopathic-drugs | https://www.govinfo.gov/content/pkg/FR-2016-12-13/pdf/2016-29770.pdf | Federal Trade Commission | 192 | The Federal Trade Commission has issued an Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs. The Statement describes the level of substantiation that the Commission expects for marketing claims for over-the-counter (OTC)... |